CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast on ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY) and reminds investors of the ...

Jefferies Financial Group downgraded shares of DENTSPLY SIRONA (NASDAQ:XRAY – Free Report) from a buy rating to a hold rating ...

Fintel reports that on January 23, 2025, Jefferies downgraded their outlook for DENTSPLY SIRONA (NasdaqGS:XRAY) from Buy to Hold. Analyst Price Forecast Suggests 21.99% Upside As of December 23, 2024, ...

Heartland Advisors, an investment management company, released its “Heartland Value Fund” fourth quarter 2024 investor letter ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.53 which represents a slight increase of $0.09 or 0.46% from the prior close of $19.44. The stock opened at $19.41 and ...

If you suffered a loss on your Dentsply Sirona Inc. (NASDAQ:XRAY) investment and want to learn about a potential recovery under the federal ...

Dentsply Sirona announces a repositioning of Byte within its aligner portfolio, emphasizing increased dentist oversight for ...

Jefferies analyst Glen Santangelo downgraded Dentsply Sirona (XRAY) to Hold from Buy with a price target of $20, down from $30. Investor ...

DENTSPLY SIRONA Inc (XRAY) stock saw a modest uptick, ending the day at $19.44 which represents a slight increase of $0.08 or 0.41% from the prior close of $19.36. The stock opened at $19.19 and ...

The law firm of Kessler Topaz Meltzer & Check, LLP (  informs investors that securities class action lawsuits have been filed against DENTSPLY SIRONA Inc. (“DENTSPLY”) (NASDAQ: XRAY) on behalf of ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DENTSPLY SIRONA Inc. ...